Dolby Laboratories Stock Price and Value Analysis

Should you buy Dolby Laboratories stock? (NYSE:DLB). Let's see how it does in our automated value investing analysis system.

  • This company has stable growth.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.

Inside the DLB Numbers

DLB Price
(Dolby Laboratories stock price per share)
[?] DLB Fair Price
(based on intrinsic value)
[?] DLB Safety Price (based on a variable margin of safety) $34.13
[?] PE Ratio versus Sector 40% higher than other Technology stocks
[?] PE Ratio versus Industry 478% higher than other Unknown stocks
[?] Cash Yield 2.68%
[?] Free Cash Flow Jitter 16%
[?] Dividend Yield 2%
Shares Shorted 764,325

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 764,325 shares shorted. With 60,971,675 shares available for purchase and an average trading volume over the past 10 trading days of 422,250, it would take at least 1.81 days for all of the short holders to cover their shorts.

Is Dolby Laboratories Stock on Sale?

We believe that Dolby Laboratories may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Dolby Laboratories looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy DLB Stock?

Does Dolby Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.